Selected research
Industry Research
Advanced Strain-Engineered Microbial Platform Industry Research Report 2026
Market perspective
The global Advanced Strain-Engineered Microbial Platform market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Advanced Strain-Engineered Microbial Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Advanced Strain-Engineered Microbial Platform market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Advanced Strain-Engineered Microbial Platform market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Advanced Strain-Engineered Microbial Platform include Ginkgo Bioworks, Amyris, Zymergen, Codexis, Novozymes, DSM-Firmenich, Evonik, Genomatica and LanzaTech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Advanced Strain-Engineered Microbial Platform market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Advanced Strain-Engineered Microbial Platform.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Advanced Strain-Engineered Microbial Platform Market by Company
Ginkgo Bioworks
Amyris
Zymergen
Codexis
Novozymes
DSM-Firmenich
Evonik
Genomatica
LanzaTech
Conagen
Arzeda
BitBio
Advanced Strain-Engineered Microbial Platform Segment by Type
Escherichia Coli
Yeast (Saccharomyces)
Filamentous Fungi
Bacillus Species
Non-Model / Custom Hosts
Advanced Strain-Engineered Microbial Platform Segment by Application
Pharmaceuticals
Industrial Chemicals
Food & Beverage
Agriculture & AgBio
Materials & Polymers
Others
Advanced Strain-Engineered Microbial Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Strain-Engineered Microbial Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Advanced Strain-Engineered Microbial Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Strain-Engineered Microbial Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Advanced Strain-Engineered Microbial Platform companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Escherichia Coli
- Yeast (Saccharomyces)
- Filamentous Fungi
- Bacillus Species
- Non-Model / Custom Hosts
Applications
- Pharmaceuticals
- Industrial Chemicals
- Food & Beverage
- Agriculture & AgBio
- Materials & Polymers
- Others
Companies covered
- Ginkgo Bioworks
- Amyris
- Zymergen
- Codexis
- Novozymes
- DSM-Firmenich
- Evonik
- Genomatica
- LanzaTech
- Conagen
- Arzeda
- BitBio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Advanced Strain-Engineered Microbial Platform by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Escherichia Coli
- 2.2.3 Yeast (Saccharomyces)
- 2.2.4 Filamentous Fungi
- 2.2.5 Bacillus Species
- 2.2.6 Non-Model / Custom Hosts
- 2.3 Advanced Strain-Engineered Microbial Platform by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals
- 2.3.3 Industrial Chemicals
- 2.3.4 Food & Beverage
- 2.3.5 Agriculture & AgBio
- 2.3.6 Materials & Polymers
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Advanced Strain-Engineered Microbial Platform Breakdown Data by Type
- 3.1 Global Advanced Strain-Engineered Microbial Platform Historic Market Size by Type (2021-2026)
- 3.2 Global Advanced Strain-Engineered Microbial Platform Forecasted Market Size by Type (2027-2032)
4 Advanced Strain-Engineered Microbial Platform Breakdown Data by Application
- 4.1 Global Advanced Strain-Engineered Microbial Platform Historic Market Size by Application (2021-2026)
- 4.2 Global Advanced Strain-Engineered Microbial Platform Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Advanced Strain-Engineered Microbial Platform Market Perspective (2021-2032)
- 5.2 Global Advanced Strain-Engineered Microbial Platform Growth Trends by Region
- 5.2.1 Global Advanced Strain-Engineered Microbial Platform Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Advanced Strain-Engineered Microbial Platform Historic Market Size by Region (2021-2026)
- 5.2.3 Advanced Strain-Engineered Microbial Platform Forecasted Market Size by Region (2027-2032)
- 5.3 Advanced Strain-Engineered Microbial Platform Market Dynamics
- 5.3.1 Advanced Strain-Engineered Microbial Platform Industry Trends
- 5.3.2 Advanced Strain-Engineered Microbial Platform Market Drivers
- 5.3.3 Advanced Strain-Engineered Microbial Platform Market Challenges
- 5.3.4 Advanced Strain-Engineered Microbial Platform Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Advanced Strain-Engineered Microbial Platform Players by Revenue
- 6.1.1 Global Top Advanced Strain-Engineered Microbial Platform Players by Revenue (2021-2026)
- 6.1.2 Global Advanced Strain-Engineered Microbial Platform Revenue Market Share by Players (2021-2026)
- 6.2 Global Advanced Strain-Engineered Microbial Platform Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Advanced Strain-Engineered Microbial Platform Head Office and Area Served
- 6.4 Global Advanced Strain-Engineered Microbial Platform Players, Product Type & Application
- 6.5 Global Advanced Strain-Engineered Microbial Platform Manufacturers Established Date
- 6.6 Global Advanced Strain-Engineered Microbial Platform Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Advanced Strain-Engineered Microbial Platform Market Size (2021-2032)
- 7.2 North America Advanced Strain-Engineered Microbial Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Advanced Strain-Engineered Microbial Platform Market Size by Country (2021-2026)
- 7.4 North America Advanced Strain-Engineered Microbial Platform Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Advanced Strain-Engineered Microbial Platform Market Size (2021-2032)
- 8.2 Europe Advanced Strain-Engineered Microbial Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Advanced Strain-Engineered Microbial Platform Market Size by Country (2021-2026)
- 8.4 Europe Advanced Strain-Engineered Microbial Platform Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Advanced Strain-Engineered Microbial Platform Market Size (2021-2032)
- 9.2 Asia-Pacific Advanced Strain-Engineered Microbial Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Advanced Strain-Engineered Microbial Platform Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Advanced Strain-Engineered Microbial Platform Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Advanced Strain-Engineered Microbial Platform Market Size (2021-2032)
- 10.2 South America Advanced Strain-Engineered Microbial Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Advanced Strain-Engineered Microbial Platform Market Size by Country (2021-2026)
- 10.4 South America Advanced Strain-Engineered Microbial Platform Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Advanced Strain-Engineered Microbial Platform Market Size (2021-2032)
- 11.2 Middle East & Africa Advanced Strain-Engineered Microbial Platform Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Advanced Strain-Engineered Microbial Platform Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Advanced Strain-Engineered Microbial Platform Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Ginkgo Bioworks
- 12.1.1 Ginkgo Bioworks Company Information
- 12.1.2 Ginkgo Bioworks Business Overview
- 12.1.3 Ginkgo Bioworks Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.1.4 Ginkgo Bioworks Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.1.5 Ginkgo Bioworks Recent Developments
- 12.2 Amyris
- 12.2.1 Amyris Company Information
- 12.2.2 Amyris Business Overview
- 12.2.3 Amyris Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.2.4 Amyris Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.2.5 Amyris Recent Developments
- 12.3 Zymergen
- 12.3.1 Zymergen Company Information
- 12.3.2 Zymergen Business Overview
- 12.3.3 Zymergen Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.3.4 Zymergen Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.3.5 Zymergen Recent Developments
- 12.4 Codexis
- 12.4.1 Codexis Company Information
- 12.4.2 Codexis Business Overview
- 12.4.3 Codexis Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.4.4 Codexis Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.4.5 Codexis Recent Developments
- 12.5 Novozymes
- 12.5.1 Novozymes Company Information
- 12.5.2 Novozymes Business Overview
- 12.5.3 Novozymes Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.5.4 Novozymes Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.5.5 Novozymes Recent Developments
- 12.6 DSM-Firmenich
- 12.6.1 DSM-Firmenich Company Information
- 12.6.2 DSM-Firmenich Business Overview
- 12.6.3 DSM-Firmenich Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.6.4 DSM-Firmenich Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.6.5 DSM-Firmenich Recent Developments
- 12.7 Evonik
- 12.7.1 Evonik Company Information
- 12.7.2 Evonik Business Overview
- 12.7.3 Evonik Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.7.4 Evonik Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.7.5 Evonik Recent Developments
- 12.8 Genomatica
- 12.8.1 Genomatica Company Information
- 12.8.2 Genomatica Business Overview
- 12.8.3 Genomatica Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.8.4 Genomatica Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.8.5 Genomatica Recent Developments
- 12.9 LanzaTech
- 12.9.1 LanzaTech Company Information
- 12.9.2 LanzaTech Business Overview
- 12.9.3 LanzaTech Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.9.4 LanzaTech Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.9.5 LanzaTech Recent Developments
- 12.10 Conagen
- 12.10.1 Conagen Company Information
- 12.10.2 Conagen Business Overview
- 12.10.3 Conagen Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.10.4 Conagen Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.10.5 Conagen Recent Developments
- 12.11 Arzeda
- 12.11.1 Arzeda Company Information
- 12.11.2 Arzeda Business Overview
- 12.11.3 Arzeda Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.11.4 Arzeda Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.11.5 Arzeda Recent Developments
- 12.12 BitBio
- 12.12.1 BitBio Company Information
- 12.12.2 BitBio Business Overview
- 12.12.3 BitBio Revenue in Advanced Strain-Engineered Microbial Platform Business (2021-2026)
- 12.12.4 BitBio Advanced Strain-Engineered Microbial Platform Product Portfolio
- 12.12.5 BitBio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst